Total Funding
44
10
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
523742
MalarVx is a bio-pharmaceutical company that develops a safe, affordable, effective malaria vaccine using innovative new technologies.
- James Davie: Founder, President and CEO
About the Company
MalarVx is a bio-pharmaceutical company that develops a safe, affordable, effective malaria vaccine using innovative new technologies. The company focuses on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine. They collaborate with researchers in non-profit
institutions, university infectious disease programs, foundations committed to solving diseases of the third world, and for-profit pharmaceutical and medical devices companies.
